Headquarters: Thousand Oaks-based Amgen needs drug to be a winner.

Headquarters: Thousand Oaks-based Amgen needs drug to be a winner.

Thousand Oaks-based Amgen will have to wait a bit longer to find out whether it can commercialize what some are saying is the biotech giant’s next blockbuster drug, denosumab, also known as Prolia...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 26 biweekly issues
  • Subscriber-only digital content for prime stories
  • Book of Lists — the most comprehensive business resource in the Valley region
Yours for only $49